Swalqol in Primary Hyperparathyroidism

Swallow related quality of life before and after parathyroidectomy will be evaluated in patients with primary hyperparathyridism.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hyperparathyroidism Endocrine System Diseases Parathyroid Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Uşak University

Uşak, 64100, Turkey (Türkiye)

About this study

Patients who will undergone parathyroidectomy for primary hyperparathyroidism will be included in the study. Swal-Qol and Sf-36 forms will be used for evaluation of quality of life before and 1 month after the surgery. The change in the quality of life and swallowing related quality of life will be evaluated.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

no diagnosis of Alzheimers disease
must be able to swallow tablets Planned operation for primary hyperparathyroidism

Exclusion criteria

secondary or tertiary hyperparathyroidism
insulin dependent diabetes
thyroid disease

Treatment and study plan

Parathyroidectomy

Procedure

routine parathyroidectomy will be done for the treatment of adenoma

Primary outcomes

Change in quality of life

Time frame: 6 months

Quality of life will be evaluated using short form 36

Sponsors and collaborators

Lead sponsor

Uşak University

Other

Registry information

Official study title

The Effect of Parathyroidectomy on Swallowing Related Quality of Life in Primary Hyperparathyroidism

Important dates

Study start: 2018
Primary completion: 2020
Study completion: 2020
First posted: May 30, 2019
Registry last updated: Jun 4, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed